A novel dengue virus detection method that couples DNAzyme and gold nanoparticle approaches
© Carter et al.; licensee BioMed Central Ltd. 2013
Received: 12 November 2012
Accepted: 8 April 2013
Published: 28 June 2013
Recent epidemics of dengue viruses (DENV) coupled with new outbreaks on the horizon have renewed the demand for novel detection methods that have the ability to identify this viral pathogen prior to the manifestation of symptoms. The ability to detect DENV in a timely manner is essential for rapid recovery from disease symptoms. A modified lab-derived 10-23 DNAzyme tethered to gold nanoparticles provides a powerful tool for the detection of viruses, such as DENV.
We examined the effectiveness of coupling DNAzyme (DDZ) activation to the salt-induced aggregation of gold nanoparticles (AuNP) to detect dengue virus (DENV) progeny in mosquito cells. A DNAzyme was designed to recognize the 5’ cyclization sequence (5’ CS) that is conserved among all DENV, and conjugated to AuNPs. DDZ-AuNP has demonstrated the ability to detect the genomic RNA of our model dengue strain, DENV-2 NGC, isolated from infected Aedes albopictus C6/36 cells. These targeting events lead to the rapid aggregation of AuNPs, resulting in a red to clear color transition of the reaction mixes, and thus positive detection of the DENV RNA genome. The inclusion of SDS in the reaction mixture permitted the detection of DENV directly from cell culture supernatants without additional sample processing. Specificity assays demonstrated detection is DENV-specific, while sensitivity assays confirm detection at levels of 1 × 101 TCID50 units. These results demonstrate DDZ-AuNP effectively detects DENV genomes in a sequence specific manner and at concentrations that are practical for field use.
We have developed an effective detection assay using DNAzyme catalysis coupled with AuNP aggregation for the detection of DENV genomes in a sequence specific manner. Full development of our novel DDZ-AuNP detection method will provide a practical, rapid, and low cost alternative for the detection of DENV in mosquito cells and tissues, and possibly infected patient serum, in a matter of minutes with little to no specialized training required.
KeywordsDengue Flavivirus DNAzyme Nanoparticles Gold Arbovirus Detection
Dengue viruses (DENV), members of the Flavivirus family of viruses, cause periodic explosive epidemics in many tropical and sub-tropical countries leading to approximately 50-100 million infections per year [1–5]. Approximately 500,000 of these are severe cases requiring hospitalization with a 2.5% fatality rate, most of which are children [1–5]. Approximately half the world’s population remains at risk for DENV infection making this pathogen one of the most dangerous viruses in the world . In 2010 there were 1.6 million cases of Dengue in the Americas alone, of which 49,000 were severe cases . Recent domestic outbreaks have occurred in the Hawaiian Islands in 2001 , Brownsville, Texas in 2005 , the Florida Keys in 2010  and other parts of southern Florida including Miami-Dade in 2011 [10, 11]. Furthermore, devastating outbreaks continue to occur in Puerto Rico [10, 12, 13], Brazil , and Pakistan , to name a few.
DENV are maintained in a cycle that involves humans and the globally disseminated Aedes aegypti mosquito . Infection with one of four antigenically distinct, but genetically related DENV serotypes (designated DENV-1, -2, -3, and -4) can result in dengue fever (DF) and/or potentially fatal dengue hemorrhagic fever (DHF) . These disease states are characterized by high fever, often with enlargement of the liver, and in severe cases circulatory and respiratory failure . While DF and DHF are endemic to tropical and subtropical regions of the world, collapse of effective vector control programs, rapid dispersal of viruses due to ease of global travel, and migration of humans from tropical to non-tropical regions has resulted in DENV outbreaks in regions that were once non-endemic to these viral pathogens.
The ability to detect DENV in a timely manner is essential to rapid recovery from disease symptoms. Currently, detection of mosquito-borne viruses in infected persons is limited to plaque assays, antigen detection assays (e.g. NS1 antigen detection), or quantitation of viral production through PCR-based methods [18–20]. These assays are currently referred to as the “gold standards” for DENV detection [21–24]. More relevant to our research, current testing of mosquito populations for arboviruses in general, but more specifically dengue viruses, has been limited to RT-PCR of mosquito pools (25-100 insects) [25–27].
The approaches mentioned above are limited by a number of pitfalls including low-throughput, labor-intensiveness, low stability of assay components at or above room temperature, and lack of portability. The requirement for specialized training and equipment and the time consuming nature of these assays limits their widespread utility for virus detection. These limitations compromise rapid diagnosis of viral infections. Additionally, these methods are not easily adapted to field environments where reliable and effective detection methods are needed. Rapid, low-tech virus detection methods that require no specialized training or education are sorely needed to provide remote areas of the world the ability to detect highly pathogenic viruses for both clinical diagnosis and epidemiological surveillance.
Full development of this detection assay would greatly enhance virus diagnostics and epidemiology by providing an assay that is more rapid, easier to use, has greater portability, and is more cost effective than current DENV detection methods.
Overview of the colorimetric detection of DENV by DNAzyme activity coupled with noncrosslinking AuNP aggregation (DDZ-AuNP)
The dengue virus detection method described below (see Figure 1) is based upon RNA aptazyme-mediated detection of small molecules, such as theophylline [28, 29]. The central limitation of using RNAzymes and aptazymes for virus detection is the inherent instability these catalytic RNAs, increasing the attractiveness of DNAzymes in detection assays.
The colorimetric detection of DENV by DDZ-AuNP can be divided into three phases: targeting/cleavage of the DENV RNA genome by DDZ, activation of AuNPs, and aggregation of AuNPs and detection (Figure 1). In the presence of DENV the 5’ and 3’ arms of DDZ bind to the 3’ and 5’ ends of a fully conserved segment that includes the 5’-3’ CS region, respectively, and in the presence of Mg2+ and heat (37°C) the viral RNA is cleaved at G149. This cleavage results in deshielding and aggregation of the AuNPs in the presence of NaCl and heat [30–32], causing a visually detectable red to clear color transition [31, 32] that can be quantified by UV/Vis spectrophotometry at 520 nm [31, 32]. If DENV are not present in the sample, the DNAzyme -tethered AuNPs remain in a dispersed state and no color loss should occur [31, 32]. Likewise, if any of the essential components such as magnesium or sodium are not present in the reaction mixture, no aggregation is possible.
Design and in vitro cleavage assessment of the DENV detection system DDZ-AuNP
The 10-23 DNAzyme is capable of cleaving RNA with high sequence specificity at target sites containing purine-pyrimidine (R-Y) junctions . We chose the 10-23 DNAzyme for use in our DENV detection system because this DNAzyme is less dependent on secondary structure formation for its activity than other DNAzymes  and would be expected to perform better in our in vitro assays where biomolecular folding would be quite variable. The design of the anti-DENV 10-23 DNAzyme, DDZ-M (Figure 2A), was based on a 10-23 DNAzyme clone that was discovered through SELEX (Systematic Evolution of Ligands by Exponential Enrichment). We designed the 5’ and 3’ arms to target the highly conserved region that includes the 5’-3’ cyclization sequence (CS) that is present in all DENV serotypes, and is required for replication of genomic RNA (Figure 2A) [48, 49].
Gold nanoparticles (AuNPs) ranging from 15 nm to 100 nm in diameter have been used in a number of detection assays [30, 50, 51]. We chose to conjugate DDZ to 15 nm AuNPs since fewer copies of single-stranded DNA are required to cover the surface of a 15 nm AuNP than any AuNP of larger size , and interaction of only 7.5% of DNAs conjugated to the 15 nm AuNPs with the substrate RNA is required to initiate aggregation of the AuNPs .
AuNP-conjugated DDZs were analyzed for their ability to cleave the DENV-2 NGC RNA in vitro. DENV-2 NGC viral RNAs were isolated from infected Ae. albopictus C6/36 cells, and incubated in a buffered solution containing 1 × 105 DDZ-M-tethered AuNPs/mL for 30 minutes at 37°C. Digestion products were then amplified by RT-PCR using heterologous and hexamer primers designed to aid in the amplification of DDZ digestion products.
Addition of an artificial DENV-2 RNA target initiates aggregation of DDZ tethered AuNPs
As an initial test of the utility of our colorimetric detection method a synthetic target was designed and synthesized that corresponds to the 5’ 170 bases of the DENV-2 NGC genome. This stretch of nucleotides included the highly conserved 5’ CS domain and the initial 74 bases of the capsid gene [49, 53, 54].
Optimization of NaCl concentration
Sodium, in the form of NaCl, is an essential component of AuNP colorimetric detection assays because this monovalent salt drives aggregation of oligonucleotide-conjugated AuNPs [30, 55–57] following the interaction of the AuNP conjugated probes with complimentary oligonucleotide targets [58, 59]. However, NaCl concentrations greater than 2 M can cause instability of conjugated AuNPs . Furthermore, published reports indicate that NaCl concentrations for effective AuNP aggregation can vary from 1.0 M to 1.5 M [51, 60]. In light of these prior observations, we evaluated the optimal NaCl concentration necessary to initiate aggregation of DDZ-M-AuNP following interaction with the DENV-2 genome.
Determination of the optimal SDS concentration for colorimetric DDZ-AuNP detection of DENV
Our DDZ-AuNP assay system demonstrated utility in detecting purified DENV-2 RNAs. However, to improve this assay for field use we needed a protocol that has speed, efficacy, and simplicity in detecting DENV RNA directly from virions. Liberating the DENV RNA genome from virion particles using a low cost, non-toxic RNA extraction reagent that is stable in the reaction buffer and does not interfere with the assay would be ideal. Sodium dodecyl sulfate (SDS) is an effective non-ionic detergent for lysing virus particles . SDS may be considered an ideal component for our colorimetric detection assays because it is non-toxic, stable in the reaction buffer, and does not require additional manipulation during lysis.
The optimal concentration of SDS was determined by adding cellular supernatants containing 1 × 106 DENV-2/mL to buffered reaction mixes containing DDZ -tethered AuNPs (DDZ-AuNP), 10 mM MgCl2 and SDS at concentrations of 0% (w/v), 0.5% (w/v) or 1.0% (w/v) (Figure 5B). Detection of DENV-2 NGC RNAs from cell culture fluid was not possible in the absence of SDS following incubation at 37°C for 30 min. Similarly, controls involving mock infected cell supernatants with or without SDS showed no red to clear color change distinctive of AuNP aggregation. However, infected cell culture supernatants displayed positive detection in as little as 5 minutes, and only in the presence of SDS and DENV-2 NGC. AuNP aggregation in the presence of 0.5% SDS and absence of DENV-2 virus particles was undetectable.
Measurement of Mg2+ resistance of oligonucleotide-tethered AuNPs
Specificity of DDZ-AuNP for DENV
An important feature of using gold nanoparticles in colorimetric detection schemes is that the aggregation of AuNPs can be detected by UV/Vis spectroscopy. Since the absorption maximum of the 15 nm AuNPs used in this detection method is 520 nm, a decrease in absorbance at 520 nm can also be used to detect and quantitate aggregation. This was tested using reaction mixtures containing cell culture supernatants from DENV infected cells (Figure 7B). UV/Vis spectrophotometric analysis at A520 showed a decrease in absorbance when DDZ-M-AuNP positively detected DENV-2, suggesting the ability to quantitate these aggregation events. Mock or CHIKV infected cell culture fluids, or AuNPs tethered with the catalytically inactive DDZin-M do not elicit a detectible change in absorbance. These results show that our colorimetric DDZ-AuNP method for DENV detection possesses utility in a UV/Vis spectrophotometric platform.
DENV shares similar symptoms with other closely related mosquito-borne flaviviruses, such as Yellow Fever (YFV) [67, 68], Japanese Encephalitis (JEV) , and Zika (ZV) [70, 71] viruses. These viruses also co-circulate with DENV and are often misdiagnosed as dengue. Therefore, a DENV detection method must demonstrate the ability to distinguish DENV, from other mosquito-borne flaviviruses. Although the 5’-3’ CS domains are largely (but not fully) conserved among flaviviruses, the entire DDZ-M binding site is not conserved among all these flaviviruses as demonstrated by a sequence alignment of our DDZ-M binding site with corresponding regions in YFV, JEV, and ZV viruses. We also performed a experimental analysis of our DDZ-M-AuNP assay to verify its ability to distinguish DENV over other flaviviruses. Separate reaction mixtures were assembled as previously described (see Figure 4), except that artificial RNA substrates comprised of the 5’ 220 nucleotides of the YFV, JEV, ZV, and DENV genomes were used as targets (Figure 7C). This stretch of nucleotides included the highly conserved 5’ CS domain and the initial 74 bases of the capsid genes of each flavivirus. Aggregation of the DDZ-M-tethered AuNPs was evident only in the presence of the artificial DENV-2 RNA substrates and not YFV, JEV, or ZV. AuNPs tethered with the catalytically inactive DDZin-M did not aggregate in the presence of any flavivirus RNA substrate tested illustrating that mere binding of an RNA substrate is not enough to elicit an aggregation response by AuNPs. These results further validated the specificity of our DENV detection method.
Summary of active and negative control DDZ-AuNP devices
Designed to detect
The DENV-1 serotype-specific DDZ-1-AuNP positively detected the DENV-1 serotype as signified by a distinctive red to clear/colorless color transition. As expected, DDZ-1-AuNP did not detect DENV-2, -3, or -4, illustrating the serotype-specific nature of this approach (Figure 7E). Likewise, each of the other serotype specific DNAzyme tethered AuNPs detected only the corresponding DENV serotype (Figure 7E and Table 1). These results demonstrated a DENV detection method that couples DNAzyme activity with AuNP aggregation to identify DENV in a serotype-specific manner. Cell culture supernatants containing the negative control CHIKV were added in lieu of DENV to further demonstrate the specificity of the serotype specific AuNPs and overall feasibility of our DENV detection assay. As expected, neither mock infected nor CHIKV infected cell culture supernatants yielded the red to clear color transition typically observed for the positive detection of DENV, showing our conjugated AuNPs were not influenced by cell or CHIKV derived oligonucleotides.
The limits of DDZ-AuNP colorimetric detection of DENV-2
Positive DENV-2 detection was evident after only 5 minutes at 37°C, and demonstrated as little as 101 DENV/ml could cause a color transition, although the samples containing 101 and 102 did not transition to a very pale purple rather than completely clear. In addition, we calculated the amount of DENV RNA corresponds to approximately 0.6 μM (for 106/ml), 6 nm (for 104/ml), 0.6nM (for 102/ml), or 0.06 nM (for 101/ml) of DENV RNA per reaction.
Further assessment of the sensitivity of our colorimetric DENV detection assay was further assessed by UV/Vis spectrophotometry using standardized titers of DENV-2 (Figure 8B). Titers of 101, 102, and 106, viruses/ml, as determined by TCID50-IFA (data not shown) and five serial dilutions originating from 101 (Dil1 through Dil5) were assayed using our colorimetric DDZ-M-AuNP as described in methods, and analyzed by UV/Vis spectrophotometry at an absorbance of 520. Positive detection of DENV-2 was evident with each sample that contained DENV-2 RNA, as demonstrated by a decrease in A520. This result is displayed as a greater –log10(520) value than the negative control Mock or CHIKV infected samples. Logarithmic interpretation of the resulting spectrophotometric measurements was performed to derive detection assay sensitivity. A linear relationship (R2 = 0.92; Figure 8B) demonstrates this assay is both sensitive and accurate. Spectrophotometric results also demonstrate our colorimetric DENV detection assay possesses the sensitivity to detect the presence of the DENV genome, even in very dilute samples (Dil4) which is of no surprise since researchers have previously detected colorimetric change associated with AuNP aggregation, by spectrophotometry, in samples containing only femtomole amounts of substrate [72, 73].
Simple and rapid diagnostic methods to screen mosquito and patient samples for the presence of viral pathogens can significantly facilitate diagnosis and treatment of virus borne diseases in field environments where sophisticated methods of virus detection are impractical. An ideal virus detection method must distinguish the target pathogen from other diseases exhibiting similar symptoms (such as malaria, leptospirosis, typhoid, typhus and Chikungunya), be highly sensitive during the acute stage of infection, provide rapid results, be inexpensive, easy to use, and stable at temperatures greater than 30°C for use in a field environment . Furthermore, DENV detection methods must show utility in epidemiological surveillance and outbreak monitoring by allowing independent detection of each serotype, and must have the ability to distinguish between primary and secondary infection .
In light of the caveats and pitfalls of the virus detection methods currently in use [18–24, 45], the aim of this research was to explore the utility of a multiple DENV serotype targeting DNAzyme, called DDZ-M, and DENV- serotype specific DNAzymes (Table 1), coupled to AuNPs for detecting DENV. DDZ was designed to target the most conserved region of the DENV genome that includes the 5’-3’CS (Figure 2A and 2B). DENV serotype-specific DNAzymes (designated DDZ-1 through DDZ-4) were engineered to bind regions of DENV that are conserved within each serotype. The demonstrated ability of DNAzymes to successfully target small stretches of RNA makes these catalytic oligonucleotides highly useful for targeting conserved regions of virus genomes. Our results suggest that DNAzyme targeting coupled with noncrosslinking AuNP aggregation satisfies many of the criteria required to have an ideal method for DENV detection.
While our DDZ-AuNP colorimetric detection system demonstrates the capacity to target the highly conserved DENV 5’ CS region, the utility of these molecules as detection agents requires a minimal subset of anti-DENV DNAzymes (DDZs) to be occupied for aggregation of AuNPs to occur. The high tolerance of DNAzymes to mismatched binding of the target oligonucleotides [74, 75] makes DNAzymes ideal for detection of viruses because they will be able to detect many closely related variants. Prior studies have demonstrated aptazymes can detect synthetically produced segments of virus genomes . We have demonstrated that under optimal reaction conditions the full length genome of DENV-2 can also be detected through the aggregation of DDZ-tethered AuNPs following the interaction of the DDZ component with the DENV-2 RNA genome.
Our anti-DENV DNAzyme (DDZ), when conjugated with AuNPs, readily detects its cognate target sequence within a synthetic 170 base segment of the DENV-2 NGC RNA corresponding to the 5’UTR, 5’CS and the 5’ 74 bases of the capsid open reading frame (Figure 4). Aggregation events result from deshielding AuNPs from sodium ions following DDZ binding to the synthesized DENV-2 target . The DDZ-AuNP conjugate also detects purified viral RNAs or genomic RNA liberated from cell culture derived DENV-2 NGC virions. In our analyses we utilized cell culture supernatants instead of patient blood sample or infected mosquitoes because it is more convenient to determine optimal experimentation parameters (e.g. SDS and NaCl concentrations (Figure 5A and 5B, respectively) and limits of detection (Figure 8) using a less complex cell culture system. These results provide the first confirmation of effective DENV detection using our DDZ-AuNP assay, and represent for the first time a catalytic nucleotide-based method can be used to detect DENV in fluid. Subsequent analyses will be required to optimize procedures for applications with infected patient serum or mosquito tissues.
Previous studies using oligonucleotide-tethered AuNPs have determined optimal aggregation occurs with NaCl concentrations from 1.0 M to 1.5 M, while concentrations ≥ 2.0 M destabilized conjugated AuNPs . In our hands, a NaCl concentration of 1.5 M allows full aggregation of DDZ-AuNP in the presence of 0.6 μM DENV-2 RNA (Figure 5A). We may infer that the color transition observed in samples containing DENV was not due to DNAzyme activity against the AuNP or non-specific interaction with cell derived oligonucleotides since the control solution containing 0 M NaCl did not yield a false positive result.
Furthermore, DDZ-AuNP aggregation in our DENV detection assays was not driven by the loss of AuNP stability in the presence of 10 mM MgCl2 (Figure 6). This was not a surprising result since resistance of DNA-probe-tethered AuNPs to MgCl2 concentrations ≤ 10 mM have been reported [30, 51].
Sodium dodecyl sulfate (SDS) proved to be an effective, low cost, detergent for directly lysing virus particles in our assay . SDS titration experiments on cell culture fluids containing DENV-2 NGC (Figure 5A). demonstrated a concentration of 0.5% (w/v) was sufficient to completely lyse DENV-2 particles without interfering with AuNP aggregation reactions. Addition of this detergent to the assay components has no effect on the cleavage or aggregation reactions.
Our DDZ-AuNP colorimetric assay is capable of distinguishing between DENV-2 NGC and CHIKV (Figure 7), two symptomatically related viral pathogens, and indicates the utility of this detection approach in regions of the world that are endemic to both DENV and CHIKV [63–65]. This increases the attractiveness and utility of the assay in epidemiological surveillance of dengue viruses in regions that are endemic to multiple pathogens that display similar symptoms. UV/Vis spectrophotometric analysis of these samples showed a fifty fold decrease in absorbance at 520 nm in the presence of DENV, demonstrating our DENV detection method has the sensitivity required for use with a spectrophotometer.
This DDZ-AuNP system allows for visual detection of DENV at titers as low as 101/mL, which translates to a concentration of 0.06nM DENV RNA (Figure 8A). This compares quite favorably to a previously reported RNA aptazyme-AuNP system that exhibits a sensitivity of 7.5nM . Further assessment of the limits of DENV detection by UV/Vis spectrophotometric analysis (Figure 8B) demonstrates this assay displays sensitivity that is consistent with previous reports of RNA detection at sub-femtomole levels using gold nanoparticle detection systems [72, 73]. Though detection of DENV RNAs at this low concentration is not physiologically relevant to what is present in posquitoes or humans, our ability to detect al this level demonstrates the power of AuNPs in detection schemes.
Moreover, despite the fact that we are detecting 1 × 106 TCID50 units, there are substantially more inactive virus particles present in a given sample [77, 78]. Therefore, by adding SDS to lyse DENV particles the sensitivity of our DDZ-AuNP detection method is enhanced for real world applications. DENV infected patients exhibit titers of 107 to 108.5 TCID50 units . Since we can detect approximately 6 to 7 orders of magnitude or more below this, our assay could potentially allow detection of DENV in infected patients prior to the manifestation of symptoms. Current DENV detection methods lack consistent bedside detection of DENV prior to the manifestation of symptoms , a caveat of NS-1 antigen detection methods . Secondly, individual Ae. aegypti mosquitoes are typically infected at a titer of 101 to 102 TCID50 units , well within the limits of detection for this assay, making it potentially ideal for surveillance of DENV in mosquito populations.
We have to date demonstrated that our multi-DENV serotype detecting DDZ-M-AuNP device can detect all four DENV serotypes directly from cell culture fluid without sample processing (Figure 7E). Furthermore, serotype-specific DDZ-tethered AuNPs have demonstrated utility in detecting each of the corresponding four DENV serotypes in a serotype specific manner (Figure 7E). For example, DDZ-1 tethered AuNPs detected the presence of DENV-1, and only the DENV-1 serotype, due to the designed specificity of the DDZ-1 DNAzyme to a region in the DENV-1 Capsid gene that is fully conserved solely among the DENV-1 serotype. The other serotype specific DDZ-tethered AuNPs possess this same feature in the detection of their corresponding DENV serotype (Figure 7E, see results summarized in Table 1). Full development of this system will provide a valuable method for the detection of DENV in a serotype specific manner in mosquito populations leading to enhanced speed and accuracy of epidemiological surveillance.
The DDZ-AuNP assay’s simplicity provides distinct advantages over other virus detection methods. The assay can be packaged as a pre-mixed reaction solution in eppendorf tubes, and may be performed without any specialized equipment or training. Furthermore, this assay is inexpensive, costing about $0.80 per sample, as compared to serological testing or PCR-based methods which can cost $2 per sample or more to perform. Assay components are stable for months at room temperature , and exhibit stability at temperatures greater than 30°C.
We anticipate further development of this assay will enable sensitive detection and discrimination of individual DENV serotypes in mosquito populations and patient derived samples as well as other virus derived RNAs. Detection prior to the onset of symptoms could allow more effective diagnosis and treatment of infected patients, and more rapid recovery from the disease. The simplicity of the assay makes it ideal as a means of early surveillance to target locations for more effective mosquito suppression strategies.
The results presented here show that the DDZ-M-AuNP, designed to be active against all forms of dengue virus, is capable of effectively detecting the DENV 2-NGC genome in a sequence specific manner. Serotype specific DNAzymes tethered to AuNPs demonstrate utility in the independent identification of DENV serotypes. Coupling DNAzyme catalysis with gold nanoparticle aggregation provides an attractive alternative to other DENV detection approaches for the identification of DENV in transformed mosquito cells and tissues.
DNAzyme, RNAprobe and AuNP
Thiol-modified and unmodified DNAzymes were synthesized and desalted by Life Science Technologies (Grand Island, NY, USA). The oligoribonucleotide target was synthesized and HPLC-purified by Life Science Technologies. Quantification of these oligonucleotides was performed with the ND-1000 spectrophotometer from NanoDrop (Wilmington, DE). Gold colloidal solutions containing 1.6 × 1012 particles/mL gold nanoparticles (AuNPs) with a diameter of 15 nm were purchased from Cytodiagnostics (Burlington, ON, CA).
Cells, virus and antibody
Ae. albopictus C6/36 cells were obtained from ATCC, and maintained in Leibovitz’s L-15 media (Atlanta Biologicals) supplemented with 10% FBS (Atlanta Biologicals), 10% TPB (triptose phosphate broth; Invitrogen/Gibco), penicillin G (100 U/ml; Invitrogen/Gibco) and streptomycin (100 U/ml; Invitrogen/Gibco). The C6/36 cells used in this study were maintained in a 28°C incubator and passaged every 4 days. Viral stocks were prepared as previously described .
The DENV strains and Genbank GenInfo identifiers for the four serotypes used in this study are as follows: DENV type 1 Hawaii: DQ672564.1, DENV type 2 strain New Guinea C (NGC): AF038403.1, DENV type 3 strain ThD3 0010 87(strain H87): AY676352.1, DENV 4 strain DENV-4/SG/06K2270DK1/2005 (strain H241): GQ398256.1.
Design of the anti-DENV DNAzyme (DDZ) and catalytically inactive form (DDZin)
DENV sequence data was obtained from the national center of biotechnology information (NCBI). Sequences representative of all four serotypes of dengue were aligned using ClustalX [54, 55]. The aligned sequences comprise the following genbank GenInfo identifiers: 12018173, 12018169, 12018171, 12659201, 2909798, 2909788, 2909786, 2909796, 6841603, 6841595, 6841605, 6841591, 6841601, 6841597, 6841593, 6841599, 6841587, 6841585, 6841589, 1000740, 1000738, 2909784, 1000736, 4926937, 4926935, 4926927, 4926929, 4926931, 2909794, 2909792, 1000742, 4926933, 2155257, 2723944, 323447, 6581076, 6581078, 2723942, 323449, 323650, 18644123, 1864412, 11119731, 19744844, 18644125, 18644127, 18643733, 4337012, 13386495, 1881708, 19071809, 13926152, 9280544, 14585842, 4926947, 4926939, 323654, 4926945, 4926943, 7329983, 7329981, 13540386, 14328931, 14485523, 323660, 17129645, 22901065, 22901063, 22901061, 1854040, 1854038, 1854036, 17129647, 24417519, 24417517, 24417515, 27656962, 24417513, 19071807, 14195698, 8927332, 14328929, 12711599, 323468, 25992053, 25992047, 25992041, 25992029, 25992025, 25992055, 25992033, 19071811, 25992043, 25992039, 25992037, 25992051, 25992031, and 25992057.
Nucleotide sequences of active and negative control DNAzymes and corresponding targets
5’Arm (5’-- > 3’)
3’Arm (5’-- > 3’)
The DDZ target site was selected by scanning the 5’CS domain for one of the purine-pyrimidine dinucleotide motifs required for DNAZyme catalysis . The primary criterion for selection was that a purine-pyrimidine motif located within the target site must be present in all strains of a given DENV serotype. Another important criterion for selecting suitable sites for DDZ cleavage was that the length of conserved flanking arms be long enough to insure specificity of the DNAzyme for the target site. The 5’ and 3’ arms of each DDZ were 9 bases in length since this was determined to be optimal for DNAzyme catalysis and provides a sufficient level of specificity to insure minimal off-target effects .
Preparation of DDZ-tethered AuNP (DDZ-AuNP)
Preparation of DDZ-M-AuNP was performed as previously described  with a few modifications. The DTT-reduced thiol-DDZ-M 5’-SH-(CH2)6-d(TTTCTCTCGGGCTAGCTACAACGAGTTTCAGCA)-3’ (SH-DDZ-M) was purified by ethanol precipitation. 3 ml of AuNP and 5 mM acetate buffer (pH 5.2) were transferred to a glass scintillation vial, capped and incubated for 24 hours at room temperature. Following incubation 5 mM Tris acetate (pH 8.2) buffer and 100 mM NaCl were added and the resulting mixture was incubated at room temperature for an additional 24 hours. These functionalized particles (500 μl) were transferred into 1.7-ml microcentrifuge tubes and centrifuged at 16,110 g at room temperature for 15 min to remove unreacted SH-DDZ-M. The nanoparticles were redispersed in 1 mL of buffer containing 100 mM NaCl, 25 mM Tris acetate, (pH 8.2) and 0.01% SDS, centrifuged again at 16,110 g at room temperature for 15 min. The supernatant was removed and the nanoparticles were dispersed in 500 μl of buffer containing 300 mM NaCl and 25 mM Tris acetate (pH 8.2), and re-centrifuged for 15 min to remove the remaining unreacted SH-DDZ-M. The cleaned DDZ-M-AuNP were redispersed into 200 μL of buffer containing 100 mM NaCl, 25 mM Tris acetate, (pH 8.2) and 0.05% SDS. This same procedure was followed for the coupling of DENV serotype-specific DTT-reduced DNAzymes: thiol-DDZ-1 5’-SH-(CH2)6-d(AGCCAxAAAGGCTAGxCTACAACGATCCTGCTG)-3’(SH-DDZ-1), thiol-DDZ-2 5’-SH-(CH2)6- d(AAGGCGTAGGCTAGCTACAACGATTCTCGCC)-3’ (SH-DDZ-2), thiol-DDZ-3 5’-SH-(CH2)6-d(AGCCAAGAGGCTAGCTACAACGATCCTGCTG)-3’ (SH-DDZ-3), and thiol DDZ-4 5’-SH-(CH2)6-d(TTGGTTCGGCTAGCTACAACGATTTTCCAG)-3’ (SH-DDZ-4).
Analysis of DDZ-tethered AuNPs in detecting a synthetic DENV-2 artificial target
DDZ-AuNPs (1 × 105/mL) were combined in a 1.5 mL eppendorff tube with 10 mM MgCl2 for optimal DNAzyme activity , 1.0 M NaCl to drive aggregation of AuNPs [30, 51, 58], and synthetic DENV-2 RNA target (7.5 nM) corresponding to the 5’ 170 nucleotides of the virus genome was added. Reaction mixes were incubated at 37°C and inspected every 5 minutes over a 30 minute period. Photographs were taken with a Nikon CoolPix S3300 camera (Nikon USA, Melville, NY).
Measurement of Mg2+ resistance of oligonucleotide-tethered AuNPs
This analysis was performed as previously described . A mixture composed of 1 μL of DDZ-tethered AuNPs, 50 mM Tris–HCl (pH 7.5), and increasing concentrations of MgCl2 (5 mM to 20 mM) 10 μL were incubated at room temperature for 0 ~ 30 min. Photos of these AuNPs at each incubation time were taken with a Nikon CoolPix S3300 camera, and the absorbances were measured with a ND-1000 spectrophotometer.
In vitro analysis of DDZ-tethered AuNPs
DENV RNA was isolated from DENV infected Ae. albopictus C6/36 cells using the QiaAmp viral RNA Mini Kit (Qiagen) according to the manufacturer’s protocol. 10 μM of eluted DENV RNA was incubated with 1 × 105 DDZ-AuNP/ml for 30 min at 37°C. 15 ul of this reaction mixture was added to a RT-PCR mix (Life Science Technologies) containing heterologous and random hexametric primers to amplify the digested fragments. These RT-PCR fragments were then separated on 1.75% agarose gels.
Sodium dodecyl sulfate (SDS) titration analysis
Ten microliters (10 μl) of cell suspension containing 1 × 106 DENV-2 NGC/mL, as determined by TCID50-IFA, was added to a mixture containing 150 mM Tris–HCl (pH 7.5), 10 mM 10 mM MgCl2, 1 × 105 DDZ-AuNP particles/mL, 1.5 M NaCl and SDS at concentrations ranging from 0% to 1% (w/v). Samples were incubated at 37°C for 30 minutes and analyzed every 5 min by visual inspection for aggregation of AuNPs, an indicator of positive detection of in cell culture DENV-2. Photographs were taken with a Nikon CoolPix S3300 camera.
NaCl titration assay
DENV -2 NGC RNA were isolated from Aedes albopictus C6/36 cells using the Qiamp Viral RNA mini kit, and added at a concentration of 0.6 μM (~10μL) to a reaction mixture containing 150 mM Tris–HCl (pH 7.5), 10 mM 10 mM MgCl2, 1 × 105 DDZ-AuNP particles/mL, 0.5% (w/v) SDS, and NaCl (0 M to 2 M). Mixes were incubated at 37°C for 30 minutes and analyzed every 5 min by visual inspection for aggregation of AuNPs. Samples were analyzed by visual inspection, and photographs taken. Positive detection of DENV-2 NGC RNAs was evident with a complete red to clear color transition occurring with the addition of 1.5 M NaCl.
Determination of DDZ-AuNP specificity
Ten microliters (10 uL) of cell culture fluid containing 1 × 106/mL DENV-2 NGC or, as a negative control, CHIKV vaccine strain 181/25  was added to a mixture containing 150 mM Tris–HCl (pH 7.5), 10 mM 10 mM MgCl2, 1 × 105 DDZ-M-AuNP,DDZin-M-AuNP or any of the serotype-specific DDZ tethered AuNPs/mL, 0.5% (w/v) SDS, and 1.5 M NaCl. Samples were mixed and incubated at 37°C for 5 minutes, photographs were taken using the Nikon CoolPix S3300 camera, and spectrophotometric analysis was performed using the ND-1000 spectrophotometer.
Analysis of DDZ-AuNP limits of DENV detection
DENV-2 NGC of the titers indicated (Figure 8) were produced as follows. A titer of 1 × 106/mL was obtained following inoculation of Ae. albopictus C6/36 cells with 0.1 MOI and incubated at 28°C for 6dpi. DENV-2 NGC were grown to titers of 1 × 104/mL and 1 × 102/mL at 3dpi and 6dpi, respectively, following inoculation of Vero cells with MOI of 0.1. DENV-2 NGC at a titer of 1 × 101/mL were produced by serial dilution of the 1 × 102/mL stock. Titers were determined by TCID50-IFA as described [53, 66].
The DENV-2 NGC titers described above served as substrates for DDZ-AuNP colorimetric assays to determine their limits of DENV detection. Ten microliters (10 μl) of each dilution stock was added to a buffered reaction mix containing 150 mM Tris–HCl (pH 7.5), 10 mM 10 mM MgCl2, 1 × 105 DDZ-M-AuNP particles/mL, 1.5 M NaCl, and 0.5% (w/v) SDS. Samples were mixed and incubated at 37°C for 5 minutes and photographs were taken Nikon CoolPix S3300 camera. UV/Vis spectrophotometric analysis was performed using the ND-1000 spectrophotometer.
We would like to thank Dr. Hsueh-Chia Chang (University of Notre Dame) and his lab for their suggestions and expert advice. This study was supported by the NIH/NIAID RO1AI048561 to MJF.
- WHO: Dengue and dengue haemorrhagic fever, Fact sheet N°117. Geneva, Switzerland: WHO: Dengue and dengue haemorrhagic fever; 2012.
- Randolph SE, Rogers DJ: The arrival, establishment and spread of exotic diseases: patterns and predictions. Nat Rev Microbiol 2010, 8: 361-371. 10.1038/nrmicro2336PubMedView Article
- Rigau-Perez JG, Clark GG, Gubler DJ, Reiter P, Sanders EJ, Vorndam AV: Dengue and dengue haemorrhagic fever. Lancet 1998, 352: 971-977. 10.1016/S0140-6736(97)12483-7PubMedView Article
- Pialoux G, Gauzere BA, Jaureguiberry S, Strobel M: Chikungunya, an epidemic arbovirosis. Lancet Infect Dis 2007, 7: 319-327. 10.1016/S1473-3099(07)70107-XPubMedView Article
- Weaver SC, Reisen WK: Present and future arboviral threats. Antiviral Res 2010, 85: 328-345. 10.1016/j.antiviral.2009.10.008PubMedPubMed CentralView Article
- Clyde K, Kyle JL, Harris E: Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol 2006, 80: 11418-11431. 10.1128/JVI.01257-06PubMedPubMed CentralView Article
- Effler PV, Pang L, Kitsutani P, Vorndam V, Nakata M, Ayers T, Elm J, Tom T, Reiter P, Rigau-Perez JG, et al.: Dengue fever, Hawaii, 2001-2002. Emerg Infect Dis 2005, 11: 742-749.PubMedPubMed CentralView Article
- Ramos MM, Mohammed H, Zielinski-Gutierrez E, Hayden MH, Lopez JL, Fournier M, Trujillo AR, Burton R, Brunkard JM, Anaya-Lopez L, et al.: Epidemic dengue and dengue hemorrhagic fever at the Texas-Mexico border: results of a household-based seroepidemiologic survey, December 2005. Am J Trop Med Hyg 2008, 78: 364-369.PubMed
- Adelman ZN, Blair CD, Carlson JO, Beaty BJ, Olson KE: Sindbis virus-induced silencing of dengue viruses in mosquitoes. Insect Mol Biol 2001, 10: 265-273. 10.1046/j.1365-2583.2001.00267.xPubMedView Article
- Anez G, Heisey DA, Espina LM, Stramer SL, Rios M: Phylogenetic analysis of dengue virus types 1 and 4 circulating in Puerto Rico and Key west, Florida, during 2010 epidemics. Am J Trop Med Hyg 2012, 87: 548-553. 10.4269/ajtmh.2012.12-0091PubMedPubMed CentralView Article
- Adalja AA, Sell TK, Bouri N, Franco C: Lessons learned during dengue outbreaks in the United States, 2001-2011. Emerg Infect Dis 2012, 18: 608-614.PubMedPubMed CentralView Article
- Ramos MM, Tomashek KM, Arguello DF, Luxemburger C, Quinones L, Lang J, Munoz-Jordan JL: Early clinical features of dengue infection in Puerto Rico. Trans R Soc Trop Med Hyg 2009, 103: 878-884. 10.1016/j.trstmh.2008.11.009PubMedView Article
- Ramos MM, Arguello DF, Luxemburger C, Quinones L, Munoz JL, Beatty M, Lang J, Tomashek KM: Epidemiological and clinical observations on patients with dengue in Puerto Rico: results from the first year of enhanced surveillance–June 2005-May 2006. Am J Trop Med Hyg 2008, 79: 123-127.PubMed
- Figueiredo LT: Dengue in Brazil. Rev Soc Bras Med Trop 2012, 45: 285. 10.1590/S0037-86822012000300001PubMedView Article
- Rai MA: Epidemic: Control of dengue fever in Pakistan. Nature 2011, 479: 41.PubMedView Article
- Roberts L: Mosquitoes and disease. Science 2002, 298: 82-83. 10.1126/science.298.5591.82PubMedView Article
- Qi RF, Zhang L, Chi CW: Biological characteristics of dengue virus and potential targets for drug design. Acta Biochim Biophys Sin (Shanghai) 2008, 40: 91-101. 10.1111/j.1745-7270.2008.00382.xView Article
- Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV: Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 1992, 30: 545-551.PubMedPubMed Central
- Gubler DJ: Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 1998, 11: 480-496.PubMedPubMed Central
- Guzman MG, Kouri G: Advances in dengue diagnosis. Clin Diagn Lab Immunol 1996, 3: 621-627.PubMedPubMed Central
- World Health Organization (WHO) and the Special Programme for Research and Training in Tropical Diseases: Dengue: guidelines for diagnosis, treatment, and Training in Tropical Diseases: prevention and control. New edition. France; 2009.
- de Oliveira PC, Pavoni DP, Queiroz MH, de Borba L, Goldenberg S, dos Santos CN, Krieger MA: Dengue virus infections: comparison of methods for diagnosing the acute disease. J Clin Virol 2005, 32: 272-277. 10.1016/j.jcv.2004.08.008View Article
- Tripathi NK, Shrivastava A, Dash PK, Jana AM: Detection of dengue virus. Meth Mol Biol 2010, 665: 51-64. 10.1007/978-1-60761-817-1_4View Article
- Shu PY, Huang JH: Current advances in dengue diagnosis. Clin Diagn Lab Immunol 2004, 11: 642-650.PubMedPubMed Central
- Jost H, Bialonski A, Storch V, Gunther S, Becker N, Schmidt-Chanasit J: Isolation and phylogenetic analysis of Sindbis viruses from mosquitoes in Germany. J Clin Microbiol 2010, 48: 1900-1903. 10.1128/JCM.00037-10PubMedPubMed CentralView Article
- Czajka C, Becker N, Poppert S, Jost H, Schmidt-Chanasit J, Kruger A: Molecular detection of Setaria tundra (Nematoda: Filarioidea) and an unidentified filarial species in mosquitoes in Germany. Parasit Vectors 2012, 5: 14. 10.1186/1756-3305-5-14PubMedPubMed CentralView Article
- Chisenhall DM, Vitek CJ, Richards SL, Mores CN: A method to increase efficiency in testing pooled field-collected mosquitoes. J Am Mosq Control Assoc 2008, 24: 311-314. 10.2987/5671.1PubMedView Article
- Ferapontova EE, Gothelf KV: Effect of serum on an RNA aptamer-based electrochemical sensor for theophylline. Langmuir 2009, 25: 4279-4283. 10.1021/la804309jPubMedView Article
- Zimmermann GR, Wick CL, Shields TP, Jenison RD, Pardi A: Molecular interactions and metal binding in the theophylline-binding core of an RNA aptamer. RNA 2000, 6: 659-667. 10.1017/S1355838200000169PubMedPubMed CentralView Article
- Ogawa A, Maeda M: Simple and rapid colorimetric detection of cofactors of aptazymes using noncrosslinking gold nanoparticle aggregation. Bioorg Med Chem Lett 2008, 18: 6517-6520. 10.1016/j.bmcl.2008.10.051PubMedView Article
- Song KM, Cho M, Jo H, Min K, Jeon SH, Kim T, Han MS, Ku JK, Ban C: Gold nanoparticle-based colorimetric detection of kanamycin using a DNA aptamer. Anal Biochem 2011, 415: 175-181. 10.1016/j.ab.2011.04.007PubMedView Article
- Englebienne P: Use of colloidal gold surface plasmon resonance peak shift to infer affinity constants from the interactions between protein antigens and antibodies specific for single or multiple epitopes. Analyst 1998, 123: 1599-1603. 10.1039/a804010iPubMedView Article
- Geyer CR, Sen D: Lanthanide probes for a phosphodiester-cleaving, lead-dependent, DNAzyme. J Mol Biol 1998, 275: 483-489. 10.1006/jmbi.1997.1475PubMedView Article
- Cieslak M, Szymanski J, Adamiak RW, Cierniewski CS: Structural rearrangements of the 10-23 DNAzyme to beta 3 integrin subunit mRNA induced by cations and their relations to the catalytic activity. J Biol Chem 2003, 278: 47987-47996. 10.1074/jbc.M300504200PubMedView Article
- Kim HK, Liu J, Li J, Nagraj N, Li M, Pavot CM, Lu Y: Metal-dependent global folding and activity of the 8-17 DNAzyme studied by fluorescence resonance energy transfer. J Am Chem Soc 2007, 129: 6896-6902. 10.1021/ja0712625PubMedView Article
- Cairns MJ, King A, Sun LQ: Optimisation of the 10-23 DNAzyme-substrate pairing interactions enhanced RNA cleavage activity at purine-cytosine target sites. Nucleic Acids Res 2003, 31: 2883-2889. 10.1093/nar/gkg378PubMedPubMed CentralView Article
- Geyer CR, Sen D: Evidence for the metal-cofactor independence of an RNA phosphodiester-cleaving DNA enzyme. Chem Biol 1997, 4: 579-593. 10.1016/S1074-5521(97)90244-1PubMedView Article
- Wieland M, Berschneider B, Erlacher MD, Hartig JS: Aptazyme-mediated regulation of 16S ribosomal RNA. Chem Biol 2010, 17: 236-242. 10.1016/j.chembiol.2010.02.012PubMedView Article
- Rueda D, Walter NG: Fluorescent energy transfer readout of an aptazyme-based biosensor. Meth Mol Biol 2006, 335: 289-310.
- Thompson KM, Syrett HA, Knudsen SM, Ellington AD: Group I aptazymes as genetic regulatory switches. BMC Biotechnol 2002, 2: 21. 10.1186/1472-6750-2-21PubMedPubMed CentralView Article
- Auslander S, Ketzer P, Hartig JS: A ligand-dependent hammerhead ribozyme switch for controlling mammalian gene expression. Mol Biosyst 2010, 6: 807-814. 10.1039/b923076aPubMedView Article
- de Silva C, Walter NG: Leakage and slow allostery limit performance of single drug-sensing aptazyme molecules based on the hammerhead ribozyme. RNA 2009, 15: 76-84.PubMedPubMed CentralView Article
- Knudsen SM, Lee J, Ellington AD, Savran CA: Ribozyme-mediated signal augmentation on a mass-sensitive biosensor. J Am Chem Soc 2006, 128: 15936-15937. 10.1021/ja064137mPubMedView Article
- Hall B, Hesselberth JR, Ellington AD: Computational selection of nucleic acid biosensors via a slip structure model. Biosens Bioelectron 2007, 22: 1939-1947. 10.1016/j.bios.2006.08.019PubMedView Article
- Cho S, Kim JE, Lee BR, Kim JH, Kim BG: Bis-aptazyme sensors for hepatitis C virus replicase and helicase without blank signal. Nucleic Acids Res 2005, 33: e177. 10.1093/nar/gni174PubMedPubMed CentralView Article
- Santoro SW, Joyce GF: A general purpose RNA-cleaving DNA enzyme. Proc Natl Acad Sci U S A 1997, 94: 4262-4266. 10.1073/pnas.94.9.4262PubMedPubMed CentralView Article
- Baum DA, Silverman SK: Deoxyribozymes: useful DNA catalysts in vitro and in vivo. Cell Mol Life Sci 2008, 65: 2156-2174. 10.1007/s00018-008-8029-yPubMedView Article
- Alvarez DE, De Lella Ezcurra AL, Fucito S, Gamarnik AV: Role of RNA structures present at the 3’UTR of dengue virus on translation, RNA synthesis, and viral replication. Virology 2005, 339: 200-212. 10.1016/j.virol.2005.06.009PubMedView Article
- Alvarez DE, Lodeiro MF, Luduena SJ, Pietrasanta LI, Gamarnik AV: Long-range RNA-RNA interactions circularize the dengue virus genome. J Virol 2005, 79: 6631-6643. 10.1128/JVI.79.11.6631-6643.2005PubMedPubMed CentralView Article
- Cao X, Ye Y, Liu S: Gold nanoparticle-based signal amplification for biosensing. Anal Biochem 2010, 417: 1-16.View Article
- Ogawa A, Maeda M: Easy design of logic gates based on aptazymes and noncrosslinking gold nanoparticle aggregation. Chem Commun (Camb) 2009, 21: 4666-4668.View Article
- Sato K, Hosokawa K, Maeda M: Non-cross-linking gold nanoparticle aggregation as a detection method for single-base substitutions. Nucleic Acids Res 2005, 33: e4. 10.1093/nar/gni007PubMedPubMed CentralView Article
- Carter JR, Keith JH, Barde PV, Fraser TS, Fraser MJ Jr: Targeting of highly conserved dengue virus sequences with anti-dengue virus trans-splicing group I introns. BMC Mol Biol 2010, 11: 84. 10.1186/1471-2199-11-84PubMedPubMed CentralView Article
- Alvarez DE, Filomatori CV, Gamarnik AV: Functional analysis of dengue virus cyclization sequences located at the 5’ and 3’UTRs. Virology 2008, 375: 223-235. 10.1016/j.virol.2008.01.014PubMedView Article
- Sato K, Onoguchi M, Sato Y, Hosokawa K, Maeda M: Non-cross-linking gold nanoparticle aggregation for sensitive detection of single-nucleotide polymorphisms: optimization of the particle diameter. Anal Biochem 2006, 350: 162-164. 10.1016/j.ab.2005.12.009PubMedView Article
- Sato K, Hosokawa K, Maeda M: Rapid aggregation of gold nanoparticles induced by non-cross-linking DNA hybridization. J Am Chem Soc 2003, 125: 8102-8103. 10.1021/ja034876sPubMedView Article
- Sato K, Sawayanagi M, Hosokawa K, Maeda M: Single-base mutation detection using neutravidin-modified polystyrene nanoparticle aggregation. Anal Sci 2004, 20: 893-894. 10.2116/analsci.20.893PubMedView Article
- Ogawa A: RNA aptazyme-tethered large gold nanoparticles for on-the-spot sensing of the aptazyme ligand. Bioorg Med Chem Lett 2011, 21: 155-159. 10.1016/j.bmcl.2010.11.048PubMedView Article
- Cao YC, Jin R, Mirkin CA: Nanoparticles with Raman spectroscopic fingerprints for DNA and RNA detection. Science 2002, 297: 1536-1540. 10.1126/science.297.5586.1536PubMedView Article
- Weill L, Louis D, Sargueil B: Selection and evolution of NTP-specific aptamers. Nucleic Acids Res 2004, 32: 5045-5058. 10.1093/nar/gkh835PubMedPubMed CentralView Article
- Peeling RW, Artsob H, Pelegrino JL, Buchy P, Cardosa MJ, Devi S, Enria DA, Farrar J, Gubler DJ, Guzman MG, et al.: Evaluation of diagnostic tests: dengue. Nat Rev Microbiol 2010, 8: S30-S38. 10.1038/nrmicro2459PubMedView Article
- Becker R, Helenius A, Simons K: Solubilization of the semliki forest virus membrane with sodium dodecyl sulfate. Biochemistry 1975, 14: 1835-1841. 10.1021/bi00680a005PubMedView Article
- Caron M, Paupy C, Grard G, Becquart P, Mombo I, Nso BB, Kassa Kassa F, Nkoghe D, Leroy EM: Recent introduction and rapid dissemination of chikungunya virus and dengue virus serotype 2 associated with human and mosquito coinfections in Gabon, central Africa. Clin Infect Dis 2012, 55: e45-e53. 10.1093/cid/cis530PubMedView Article
- Taraphdar D, Sarkar A, Mukhopadhyay BB, Chatterjee S: A comparative study of clinical features between monotypic and dual infection cases with Chikungunya virus and dengue virus in West Bengal, India. Am J Trop Med Hyg 2012, 86: 720-723. 10.4269/ajtmh.2012.11-0704PubMedPubMed CentralView Article
- Kalawat U, Sharma KK, Reddy SG: Prevalence of dengue and chickungunya fever and their co-infection. Indian J Pathol Microbiol 2012, 54: 844-846.
- Nawtaisong P, Keith J, Fraser T, Balaraman V, Kolokoltsov A, Davey RA, Higgs S, Mohammed A, Rongsriyam Y, Komalamisra N, Fraser MJ Jr: Effective suppression of dengue fever virus in mosquito cell cultures using retroviral transduction of hammerhead ribozymes targeting the viral genome. Virol J 2009, 6: 73. 10.1186/1743-422X-6-73PubMedPubMed CentralView Article
- Reed W, Carroll J, Agramonte A, Lazear JW: The etiology of yellow fever-a preliminary note. Publ Health Pap Rep 1900, 26: 37-53.
- Tejada E: Yellow fever and the Indiana connection. An historical note about Dr. Walter Reed (1851-1902). Indiana Med 1985, 78: 906-907.PubMed
- Kuwayama M, Ito M, Takao S, Shimazu Y, Fukuda S, Miyazaki K, Kurane I, Takasaki T: Japanese encephalitis virus in meningitis patients, Japan. Emerg Infect Dis 2005, 11: 471-473.PubMedPubMed Central
- Macnamara FN: Zika virus: a report on three cases of human infection during an epidemic of jaundice in Nigeria. Trans R Soc Trop Med Hyg 1954, 48: 139-145. 10.1016/0035-9203(54)90006-1PubMedView Article
- Marchette NJ, Garcia R, Rudnick A: Isolation of Zika virus from Aedes aegypti mosquitoes in Malaysia. Am J Trop Med Hyg 1969, 18: 411-415.PubMed
- Liu Y, Wu Z, Zhou G, He Z, Zhou X, Shen A, Hu J: Simple, rapid, homogeneous oligonucleotides colorimetric detection based on non-aggregated gold nanoparticles. Chem Commun (Camb) 2012, 48: 3164-3166. 10.1039/c2cc16741gView Article
- Bai X, Shao C, Han X, Li Y, Guan Y, Deng Z: Visual detection of sub-femtomole DNA by a gold nanoparticle seeded homogeneous reduction assay: toward a generalized sensitivity-enhancing strategy. Biosens Bioelectron 2010, 25: 1984-1988. 10.1016/j.bios.2010.01.012PubMedView Article
- Cairns MJ, Hopkins TM, Witherington C, Sun LQ: The influence of arm length asymmetry and base substitution on the activity of the 10-23 DNA enzyme. Antisense Nucleic Acid Drug Dev 2000, 10: 323-332. 10.1089/oli.1.2000.10.323PubMedView Article
- Santoro SW, Joyce GF: Mechanism and utility of an RNA-cleaving DNA enzyme. Biochemistry 1998, 37: 13330-13342. 10.1021/bi9812221PubMedView Article
- Williams DHaF I: Spectroscopic Methods in Organic Chemistry. 5th edition. Blacklick, Ohio, U.S.A: Mc Graw-Hill; 1995.
- Aaskov J, Buzacott K, Thu HM, Lowry K, Holmes EC: Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes. Science 2006, 311: 236-238. 10.1126/science.1115030PubMedView Article
- Li D, Lott WB, Lowry K, Jones A, Thu HM, Aaskov J: Defective interfering viral particles in acute dengue infections. PLoS One 2011, 6: e19447. 10.1371/journal.pone.0019447PubMedPubMed CentralView Article
- Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Endy TP, Raengsakulrach B, Rothman AL, Ennis FA, Nisalak A: Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000, 181: 2-9. 10.1086/315215PubMedView Article
- Kabra SK, Jain Y, Singhal T, Ratageri VH: Dengue hemorrhagic fever: clinical manifestations and management. Indian J Pediatr 1999, 66: 93-101. 10.1007/BF02752362PubMedView Article
- Tricou V, Vu HT, Quynh NV, Nguyen CV, Tran HT, Farrar J, Wills B, Simmons CP: Comparison of two dengue NS1 rapid tests for sensitivity, specificity and relationship to viraemia and antibody responses. BMC Infect Dis 2010, 10: 142. 10.1186/1471-2334-10-142PubMedPubMed CentralView Article
- Apte-Deshpande A, Paingankar M, Gokhale MD, Deobagkar DN: Serratia odorifera a midgut inhabitant of Aedes aegypti mosquito enhances its susceptibility to dengue-2 virus. PLoS One 2012, 7: e40401. 10.1371/journal.pone.0040401PubMedPubMed CentralView Article
- Liu J, Lu Y: Preparation of aptamer-linked gold nanoparticle purple aggregates for colorimetric sensing of analytes. Nat Protoc 2006, 1: 246-252. 10.1038/nprot.2006.38PubMedView Article
- Plante K, Wang E, Partidos CD, Weger J, Gorchakov R, Tsetsarkin K, Borland EM, Powers AM, Seymour R, Stinchcomb DT, et al.: Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism. PLoS Pathog 2011, 7: e1002142. 10.1371/journal.ppat.1002142PubMedPubMed CentralView Article
- Li Y, Sen D: Toward an efficient DNAzyme. Biochemistry 1997, 36: 5589-5599. 10.1021/bi962694nPubMedView Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.